In 1988, Reaven described the insulin-stimulated glucose uptake resistance involved in the development of non-insulin-dependent diabetes mellitus (NIDDM), hypertension and coronary artery disease (CAD) as “syndrome x”. This evidence concerns the gene INS and hypertensive disorder.